ReviewThe EPMA journal2022

DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine.

Guodong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.